Search: PFE - Buzzberg

Date	Ticker	Price	Dir	Speaker	Thesis	Source
Feb 18	PFE	$27.37 $27.37 +0.0%	N/A	Finnhub News	—	Finnhub - PFE Pfizer Colorectal Cancer Trial Win Adds Weigh...
Feb 18	PFE	$27.37 $27.37 +0.0%	N/A	Finnhub News	—	Finnhub - PFE Pfizer (PFE) Valuation Check After Recent Sha...
Feb 18	PFE	$27.37 $27.37 +0.0%	N/A	Finnhub News	—	Finnhub - PFE Fallopian Tube Cancer Market Research Report ...
Feb 17	PFE	$27.37 $27.37 +0.0%	LONG	Crystal Tse Deals Reporter, Bloomberg	Activist activity is surging. Elliott has a >10% stake in Norwegian Cruise Line (NCLH). Starboard is pushing TripAdvisor (TRIP) for a sale. Jana Partners is in Pfizer (PFE). Danaher (DHR) is acquiring Masimo (MASI). Activists (Elliott, Starboard) are aggressively pushing for immediate value unlocking via sales, splits, or operational overhauls. This historically creates a floor for the stock price and drives short-term upside as the market prices in M&A premiums. Long the activist targets (NCLH, TRIP, MASI). Deal talks fail; activists exit without forcing change.	Bloomberg Markets Open Interest 2/17/2026
Feb 17	PFE	$27.37 $27.37 +0.0%	N/A	Finnhub News	—	Finnhub - PFE Pfizer: The Rebound Looks Unsustainable
Feb 17	PFE	$27.37 $27.37 +0.0%	N/A	Finnhub News	—	Finnhub - PFE CorMedix Down 27% in 3 Months: Is It Time to ...
Feb 17	PFE	$27.37 $27.37 +0.0%	N/A	Finnhub News	—	Finnhub - PFE Pfizer Trial Updates Test Investor Views On P...
Feb 17	PFE	$27.37 $27.37 +0.0%	N/A	Finnhub News	—	Finnhub - PFE ViiV Healthcare showcases long-acting HIV inn...
Feb 17	PFE	$27.37 $27.37 +0.0%	N/A	Finnhub News	—	Finnhub - PFE How Is The Market Feeling About Pfizer Inc?
Feb 17	PFE	$27.37 $27.37 +0.0%	N/A	Finnhub News	—	Finnhub - PFE Pfizer’s BRAFTOVI Regimen Improves Progressio...
Feb 17	PFE	$27.37 $27.37 +0.0%	N/A	Finnhub News	—	Finnhub - PFE Pfizer's Cancer Drug Combo Shows Strong Resul...
Feb 17	PFE	$27.37 $27.37 +0.0%	N/A	Finnhub News	—	Finnhub - PFE Pfizer Announces Topline PFS Survival Results...
Feb 17	PFE	$27.37 $27.37 +0.0%	N/A	Finnhub News	—	Finnhub - PFE 2 Value Stocks Worth Your Attention and 1 We ...
Feb 14	PFE	$27.58 $27.37 -0.8%	LONG	Finnhub News	The headline asks to identify a top pharmaceutical stock with long-term growth potential.	Finnhub - PFE What Is One of the Best Pharmaceutical Stocks...
Feb 14	PFE	$27.58 $27.37 -0.8%	LONG	Finnhub News	Oric Pharmaceuticals presented positive future development plans, including a significant Phase 3 trial target.	Finnhub - PFE Oric Pharmaceuticals Highlights 2025 Mileston...
Feb 14	PFE	$27.58 $27.37 -0.8%	SHORT	Finnhub News	Daiwa lowered its rating on Pfizer to Neutral after reviewing the company's 2025 earnings forecast.	Finnhub - PFE Daiwa Downgrades Pfizer (PFE) to Neutral Foll...
Feb 13	PFE	$27.58 $27.37 -0.8%	N/A	Finnhub News	—	Finnhub - PFE Pfizer Obesity And Hemophilia Advances Spark ...
Feb 13	PFE	$27.58 $27.37 -0.8%	N/A	Finnhub News	—	Finnhub - PFE Alnylam Hit Hard As Investors Forced To Revis...
Feb 13	PFE	$27.58 $27.37 -0.8%	N/A	Finnhub News	—	Finnhub - PFE Is Pfizer Inc. (PFE) One of the Best Medical ...
Feb 13	PFE	$27.58 $27.37 -0.8%	N/A	Finnhub News	—	Finnhub - PFE Meet the 6.3% Yield Dividend Stock That Could...
Feb 12	PFE	$27.47 $27.37 -0.4%	N/A	Finnhub News	—	Finnhub - PFE Kahn Brothers Reduces Stake in Pfizer Inc by ...
Feb 12	PFE	$27.47 $27.37 -0.4%	N/A	Finnhub News	—	Finnhub - PFE MDGL Strengthens MASH Franchise With New Gene...
Feb 12	PFE	$27.47 $27.37 -0.4%	N/A	Finnhub News	—	Finnhub - PFE Here Are Thursday’s Top Wall Street Analyst R...
Feb 12	PFE	$27.47 $27.37 -0.4%	N/A	Finnhub News	—	Finnhub - PFE Pfizer Hemophilia And Obesity Updates Reshape...
Feb 11	PFE	$27.73 $27.37 -1.3%	N/A	Finnhub News	—	Finnhub - PFE Pfizer Reports Strong Earnings Outlook - Unus...
Feb 11	PFE	$27.73 $27.37 -1.3%	N/A	Finnhub News	—	Finnhub - PFE Pfizer (PFE) Closes 2025 on Solid Note, Retur...
Feb 11	PFE	$27.73 $27.37 -1.3%	N/A	Finnhub News	—	Finnhub - PFE CorMedix Banks on DefenCath Sales in Q4 as Me...

Search

Trade Ideas (27)